ORGANOVO HOLDINGS, INC.

Display and export data

General & Ratios

Financial Statements

In the 'original' view, the statements are displayed just as they are being reported by the company.

In the 'standardised' view, the statements are displayed in a standardised format (line items are identical for all companies).

Add data

Edit or review data

Legend (for Financial Statements)

Click on a coloured field in the profile to review the data

Close sidebar

Loading: 100%

ORGANOVO HOLDINGS, INC. listed company

no logo available

General Information

Investor relations pageIR page	no data available
Founding year	no data available
Headquarter	, , no data available
Employees	113 (as per FY 2016)no data available
Sector	Medical Diagnostics & Research, HealthcareMedical Diagnostics & Research, Healthcareno data available

Ticker	ONVOno data available
Financial year endsFY ends	End of Marchno data available

Stock Information (historical prices adjusted for splits and dividends)

dates	Closing price (adj.)
13.10.2017	1.56
11.10.2017	1.68
04.10.2017	2.04
27.09.2017	2.15
20.09.2017	2.06
13.09.2017	2.34
06.09.2017	2.16
30.08.2017	1.95
23.08.2017	1.88
16.08.2017	2.08
09.08.2017	2.08
02.08.2017	2.13
26.07.2017	2.38
19.07.2017	2.37
12.07.2017	2.67
05.07.2017	2.71
27.06.2017	2.66
20.06.2017	2.66
13.06.2017	2.67
06.06.2017	2.87
30.05.2017	2.98
23.05.2017	2.83
16.05.2017	2.93
09.05.2017	2.71
02.05.2017	2.80
25.04.2017	2.78
18.04.2017	2.69
11.04.2017	3.04
04.04.2017	3.03
28.03.2017	3.03
21.03.2017	3.01
14.03.2017	2.91
07.03.2017	2.87
28.02.2017	3.12
21.02.2017	3.00
14.02.2017	2.98
07.02.2017	3.67
31.01.2017	3.69
24.01.2017	3.49
17.01.2017	3.55
10.01.2017	3.83
03.01.2017	3.66
27.12.2016	3.79
19.12.2016	3.75
12.12.2016	3.39
05.12.2016	3.10
28.11.2016	3.13
21.11.2016	3.19
14.11.2016	3.28
07.11.2016	2.82
31.10.2016	2.49
24.10.2016	2.88
17.10.2016	3.64

no share price data source found

Share price data requested

Key Figures

Last Closing Price as per Oct 13, 2017, in USD	1.56n/a
Market Capitalisation in million USD	144n/a
Enterprise Value in million USD	82n/a
Common Shares Outstanding as per Mar 31, 2016	92,391,989n/a
Preferred Shares Outstanding as per Mar 31, 2016	n/a
Average Basic Shares Outstanding TTM	90,057,356n/a
Average Diluted Shares Outstanding TTM	n/a
Index Membership	, US 3000 n/a

Business Summary

Organovo Holdings Inc is a development-stage company. It is engaged in developing and commercializing functional three-dimensional human tissues.

no data available

Key Financials & Ratios (all figures TTM as per , million USD, full statements further below)

Profit & Loss

Revenues	0n/a
Gross Profit	0n/a
Operating Income	0n/a
EBITDA	0n/a
Net Profit	0n/a

Balance Sheet

Cash and Cash Equivalents	62n/a
Receivables	0n/a
Total Current Assets	64n/a
PP&E	4n/a
Total Assets	68n/a
Accounts Payable	1n/a
Current Debt	0n/a
Total Current Liabilities	4n/a
Long-Term Debt	0n/a
Total Liabilities	5n/a
Total Equity	62n/a

Cash Flow

Depreciation & Amortisation	1n/a
Change in Working Capital	0n/a
Operating Cash Flow	-29n/a
Net Change in PP&E and Intangibles	-2n/a
Investing Cash Flow	-2n/a
Dividends Paid	0n/a
Financing Cash Flow	43n/a
Total Change in Cash	12n/a
Free Cash Flow	0n/a

Profitability Ratios

Gross Margin	0.0%n/a
Operating Margin	0.0%n/a
Net Profit Margin	0.0%n/a
Return on Equity	0.0%n/a
Return on Assets	0.0%n/a

Per Share Figures

Basic EPS	n/a
Diluted EPS	n/a
Sales per Share	n/a
Book Value per Share	0.69n/a
FCF per Share	n/a
Dividends per Share	0.00n/a

Price Multiples

Price to Earnings Ratio	n/a
Price to Sales Ratio	n/a
Price to Book Value	2.26n/a
Price to Free Cash Flow	n/a

Valuation Metrics

EV/EBITDA	n/a
EV/Sales	n/a
Book to Market Value	0.43n/a

Other Ratios

Current Ratio	1,417.6%n/a
Liabilities to Equity Ratio	8.7%n/a
Debt to Assets Ratio	0.0%n/a

Profit & Loss StatementP&L data quality: 0% (?)

edit

No data available yet

Loading data...

No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.

Standardised statements can't be displayed.

Reason:

No data available for the selected time periods

in million USD	FY '11	FY '12	FY '13	FY '14	FY '15	FY '16
Revenue	1	1	1	0	1	1
Sales & Services Revenue	0	0	0	0	0	0
Financing Revenue	0	0	0	0	0	0
Other Revenue	0	0	0	0	0	0
Cost of revenue	0	0	0	0	0	0
Cost of Goods & Services	0	0	0	0	0	0
Cost of Financing Revenue	0	0	0	0	0	0
Cost of Other Revenue	0	0	0	0	0	0
Gross Profit	1	1	1	0	1	1
Other Operating Income	0	0	0	0	0	0
Operating Expenses	-2	-3	-11	-21	-31	-40
Selling, General & Administrative	-1	-2	-7	-13	-18	-22
Selling & Marketing	0	0	0	0	0	0
General & Administrative	0	0	0	0	0	0
Research & Development	-1	-1	-3	-8	-13	-18
Depreciation & Amortization	0	0	0	0	0	0
Provision For Doubtful Accounts	0	0	0	0	0	0
Other Operating Expense	0	0	0	0	0	0
Operating Income (Loss)	-1	-2	-9	-21	-30	-39
Non-Operating Income (Loss)	0	2	1	0	0	0
Interest Expense, net	0	2	1	0	0	0
Interest Expense	0	0	0	0	0	0
Interest Income	0	0	0	0	0	0
Other Investment Income (Loss)	0	0	0	0	0	0
Foreign Exchange Gain (Loss)	0	0	0	0	0	0
Income (Loss) from Affiliates	0	0	0	0	0	0
Other Non-Operating Income (Loss)	0	0	0	0	0	0
Pretax Income (Loss), Adjusted	-1	0	-8	-21	-30	-39
Abnormal Gains (Losses)	0	0	33	5	0	0
Acquired In-Process R&D	0	0	0	0	0	0
Merger / Acquisition Expense	0	0	0	0	0	0
Abnormal Derivatives	0	0	0	0	0	0
Disposal of Assets	0	0	0	0	0	0
Early extinguishment of Debt	0	0	0	0	0	0
Asset Write-Down	0	0	0	0	0	0
Impairment of Goodwill & Intangibles	0	0	0	0	0	0
Sale of Business	0	0	0	0	0	0
Legal Settlement	0	0	0	0	0	0
Restructuring Charges	0	0	0	0	0	0
Sale of and Unrealized Investments	0	0	0	0	0	0
Insurance Settlement	0	0	0	0	0	0
Other Abnormal Items	0	0	0	0	0	0
Pretax Income (Loss)	-1	0	25	-15	-31	-39
Income Tax (Expense) Benefit, net	0	0	0	0	0	0
Current Income Tax	0	0	0	0	0	0
Deferred Income Tax	0	0	0	0	0	0
Tax Allowance/Credit	0	0	0	0	0	0
Income (Loss) from Affiliates, net of taxes	0	0	0	0	0	0
Income (Loss) from Continuing Operations	-1	0	25	-15	-31	-39
Net Extraordinary Gains (Losses)	0	0	0	0	0	0
Discontinued Operations	0	0	0	0	0	0
XO & Accounting Charges & Other	0	0	0	0	0	0
Income (Loss) Including Minority Interest	-1	0	25	-15	-31	-39
Minority Interest	0	0	0	0	0	0
Net Income	-1	0	25	-15	-31	-39
Preferred Dividends	0	0	0	0	0	0
Other Adjustments	0	0	0	0	0	0
Net Income Available to Common Shareholders	-1	0	25	-15	-31	-39

Remarks	restated on May 24, 2013 n/a calculated values,	restated on Jun 10, 2014 n/a calculated values,	restated on Jun 9, 2015 n/a calculated values,	restated on Jun 9, 2016 n/a calculated values,	restated on Jun 9, 2016 n/a calculated values,	restated on Jun 9, 2016 n/a calculated values,

Balance SheetBS data quality: 100% (?)

edit

No data available yet

Loading data...

No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.

Standardised statements can't be displayed.

Reason:

No data available for the selected time periods

in million USD	FY '11	FY '12	FY '13	FY '14	FY '15	FY '16
Assets
Cash, Cash Equivalents & Short Term Investments	0	15	16	48	50	62
Cash & Cash Equivalents	0	15	16	48	50	62
Short Term Investments	0	0	0	0	0	0
Accounts & Notes Receivable	0	0	0	0	0	0
Accounts Receivable, Net	0	0	0	0	0	0
Notes Receivable, Net	0	0	0	0	0	0
Unbilled Revenues	0	0	0	0	0	0
Inventories	0	0	0	0	0	0
Raw Materials	0	0	0	0	0	0
Work In Process	0	0	0	0	0	0
Finished Goods	0	0	0	0	0	0
Other Inventory	0	0	0	0	0	0
Other Short Term Assets	0	1	0	1	1	1
Prepaid Expenses	0	1	0	1	1	1
Derivative & Hedging Assets	0	0	0	0	0	0
Assets Held-for-Sale	0	0	0	0	0	0
Deferred Tax Assets	0	0	0	0	0	0
Income Taxes Receivable	0	0	0	0	0	0
Discontinued Operations	0	0	0	0	0	0
Miscellaneous Short Term Assets	0	0	0	0	0	0
Total Current Assets	1	16	16	49	51	64
Property, Plant & Equipment, Net	0	1	1	1	2	4
Property, Plant & Equipment	0	0	0	0	0	0
Accumulated Depreciation	0	0	0	0	0	0
Long Term Investments & Receivables	0	0	0	0	0	0
Long Term Investments	0	0	0	0	0	0
Long Term Marketable Securities	0	0	0	0	0	0
Long Term Receivables	0	0	0	0	0	0
Other Long Term Assets	0	0	0	0	0	0
Intangible Assets	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0
Other Intangible Assets	0	0	0	0	0	0
Prepaid Expense	0	0	0	0	0	0
Deferred Tax Assets	0	0	0	0	0	0
Derivative & Hedging Assets	0	0	0	0	0	0
Prepaid Pension Costs	0	0	0	0	0	0
Discontinued Operations	0	0	0	0	0	0
Investments in Affiliates	0	0	0	0	0	0
Miscellaneous Long Term Assets	0	0	0	0	0	0
Total Noncurrent Assets	0	1	1	1	2	4
Total Assets	1	17	17	50	53	68

Liabilities and owners' equity
Payables & Accruals	1 1120000	1 1406000	1 1421000	1 1148000	4 3644000	3 3237000
Accounts Payable	1 658000	0 425000	1 641000	0 326000	1 1387000	1 787000
Accrued Taxes	0 0	0 0	0 0	0 0	0 0	0 0
Interest & Dividends Payable	0 24000	0 0	0 0	0 0	0 0	0 0
Other Payables & Accruals	0 438000	1 981000	1 780000	1 822000	2 2257000	2 2450000
Short Term Debt	1 704000	0 10000	0 10000	0 10000	0 5000	0 0
Short Term Borrowings	0 0	0 0	0 0	0 0	0 0	0 0
Short Term Capital Leases	0 0	0 0	0 0	0 0	0 0	0 0
Current Portion of Long Term Debt	0 0	0 0	0 0	0 0	0 0	0 0
Other Short Term Liabilities	1 1420000	21 20619000	7 6951000	1 735000	1 1112000	1 1253000
Deferred Revenue	0 153000	0 0	0 53000	0 13000	0 227000	1 1110000
Derivatives & Hedging	1 1267000	21 20619000	7 6898000	0 377000	0 126000	0 4000
Deferred Tax Liabilities	0 0	0 0	0 0	0 0	0 0	0 0
Discontinued Operations	0 0	0 0	0 0	0 0	0 0	0 0
Miscellaneous Short Term Liabilities	0 0	0 0	0 0	0 345000	1 759000	0 139000
Total Current Liabilities	3 3244000	22 22035000	8 8382000	2 1893000	5 4761000	4 4490000
Long Term Debt	0 0	0 0	0 0	0 0	0 0	0 0
Long Term Borrowings	0 0	0 0	0 0	0 0	0 0	0 0
Long Term Capital Leases	0 0	0 0	0 0	0 0	0 0	0 0
Other Long Term Liabilities	0 0	0 17000	0 24000	0 9000	0 32000	1 905000
Accrued Liabilities	0 0	0 0	0 0	0 0	0 0	0 0
Pension Liabilities	0 0	0 0	0 0	0 0	0 0	0 0
Pensions	0 0	0 0	0 0	0 0	0 0	0 0
Other Post-Retirement Benefits	0 0	0 0	0 0	0 0	0 0	0 0
Deferred Compensation	0 0	0 0	0 0	0 0	0 0	0 0
Deferred Revenue	0 0	0 0	0 9000	0 4000	0 32000	0 0
Deferred Tax Liabilities	0 0	0 0	0 0	0 0	0 0	0 0
Derivatives & Hedging	0 0	0 0	0 0	0 0	0 0	0 0
Discontinued Operations	0 0	0 0	0 0	0 0	0 0	0 0
Miscellaneous Long Term Liabilities	0 0	0 17000	0 15000	0 5000	0 0	1 905000
Total Noncurrent Liabilities	0 0	0 17000	0 24000	0 9000	0 32000	1 905000
Total Liabilities	3 3244000	22 22052000	8 8406000	2 1902000	5 4793000	5 5395000
Preferred Equity	0 0	0 0	0 0	0 0	0 0	0 0
Share Capital & Additional Paid-In Capital	5 4857000	45 44942000	75 75334000	140 140497000	171 170991000	223 223051000
Common Stock	0 0	0 0	0 0	0 0	0 0	0 0
Additional Paid in Capital	0 0	0 0	0 0	0 0	0 0	0 0
Other Share Capital	0 0	0 0	0 0	0 0	0 0	0 0
Treasury Stock	0 0	0 0	0 0	0 0	0 0	0 0
Retained Earnings	-7 -6692000	-50 -50245000	-66 -66365000	-92 -92213000	-122 -122295000	-161 -160870000
Other Equity	0 0	0 0	0 0	0 0	0 0	0 0
Equity Before Minority Interest	-2 -1835000	-5 -5303000	9 8969000	48 48284000	49 48696000	62 62181000
Minority Interest	0 0	0 0	0 0	0 0	0 0	0 0
Total Equity	-2 -1835000	-5 -5303000	9 8969000	48 48284000	49 48696000	62 62181000
Total Liabilities & Equity	1 1409000	17 16749000	17 17375000	50 50186000	53 53489000	68 67576000

Remarks	restated on Mar 15, 2013 n/a	restated on Mar 15, 2013 n/a	restated on Jun 10, 2014 n/a	restated on Jun 9, 2015 n/a	restated on Jun 9, 2016 n/a	restated on Jun 9, 2016 n/a

Cash Flow StatementCF data quality: 96% (?)

edit

No data available yet

Loading data...

No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.

Standardised statements can't be displayed.

Reason:

No data available for the selected time periods

in million USD	FY '11	FY '12	FY '13	FY '14	FY '15	FY '16
Net Income/Starting Line	-1	-4	-44	-26	-30	-39
Net Income	0	0	0	0	0	0
Net Income From Discontinued Operations	0	0	0	0	0	0
Other Adjustments	0	0	0	0	0	0
Depreciation & Amortization	0	0	0	0	0	1
Non-Cash Items	0	2	34	10	7	8
Stock-Based Compensation	0	0	0	0	0	0
Deferred Income Taxes	0	0	0	0	0	0
Other Non-Cash Adjustments	0	0	0	0	0	0
Change in Working Capital	0	0	-1	0	3	0
(Increase) Decrease in Accounts Receivable	0	0	0	0	0	0
(Increase) Decrease in Inventories	0	0	0	0	0	0
Increase (Decrease) in Accounts Payable	0	0	0	0	0	0
Increase (Decrease) in Other	0	0	0	0	0	0
Net Cash From Discontinued Operations (operating)	0	0	0	0	0	0
Cash from Operating Activities	-1	-2	-10	-16	-20	-29
Change in Fixed Assets & Intangibles	0	0	0	0	-2	-2
Disposition of Fixed Assets & Intangibles	0	0	0	0	0	0
Disposition of Fixed Assets	0	0	0	0	0	0
Disposition of Intangible Assets	0	0	0	0	0	0
Acquisition of Fixed Assets & Intangibles	0	0	0	0	0	0
Purchase of Fixed Assets	0	0	0	0	0	0
Acquisition of Intangible Assets	0	0	0	0	0	0
Other Change in Fixed Assets & Intangibles	0	0	0	0	0	0
Net Change in Long Term Investment	0	0	0	0	0	0
Decrease in Long Term Investment	0	0	0	0	0	0
Increase in Long Term Investment	0	0	0	0	0	0
Net Cash From Acquisitions & Divestitures	0	0	0	0	0	0
Net Cash from Divestitures	0	0	0	0	0	0
Cash for Acqusition of Subsidiaries	0	0	0	0	0	0
Cash for Joint Ventures	0	0	0	0	0	0
Net Cash from Other Acquisitions	0	0	0	0	0	0
Other Investing Activities	0	0	0	0	0	0
Net Cash From Discontinued Operations (investing)	0	0	0	0	0	0
Cash from Investing Activities	0	0	0	0	-2	-2
Dividends Paid	0	0	0	0	0	0
Cash From (Repayment of) Debt	0	0	0	0	0	0
Cash From (Repayment of) Short Term Debt, net	0	0	0	0	0	0
Cash From (Repayment of) Long Term Debt, net	0	0	0	0	0	0
Repayments of Long Term Debt	0	0	0	0	0	0
Cash From Long Term Debt	0	0	0	0	0	0
Cash From (Repurchase of) Equity	1	3	25	48	23	43
Increase in Capital Stock	1	3	25	48	23	43
Decrease in Capital Stock	0	0	0	0	0	0
Other Financing Activities	0	0	0	0	0	0
Net Cash From Discontinued Operations (financing)	0	0	0	0	0	0
Cash from Financing Activities	1	2	25	48	23	43
Net Cash Before Disc. Operations and FX	0	0	14	33	2	12
Change in Cash from Disc. Operations and Other	0	0	0	0	0	0
Net Cash Before FX	0	0	14	33	2	12
Effect of Foreign Exchange Rates	0	0	0	0	0	0
Net Changes in Cash	0	0	14	33	2	12

Remarks	restated on May 24, 2013 n/a calculated values,	restated on Jun 10, 2014 n/a calculated values,	restated on Jun 9, 2015 n/a calculated values,	restated on Jun 9, 2016 n/a calculated values,	restated on Jun 9, 2016 n/a calculated values,	restated on Jun 9, 2016 n/a calculated values,

Some of the data shown on this page is provided for free by IEX